Robbins Geller Obtains Preliminary Approval of $400 million Securities Class Action Settlement Against Pfizer Inc.
On March 16, 2015, the Court entered an order granting preliminary approval to the $400 million settlement obtained by Robbins Geller on the eve of trial against Pfizer.
The final approval hearing is currently scheduled for July 30, 2015 at 2:30 p.m. at the U.S. District Court for the Southern District of New York, 500 Pearl Street, Courtroom 14D, New York, New York 10007. Additional information about the settlement, case documents, and deadlines associated with the settlement can be found at http://www.pfizersecuritiessettlement.com/
Read More Firm News
- The National Law Journal Recognizes Robbins Geller as 2021 Elite Trial Lawyers Finalist in Securities Litigation, Class Action, and Privacy/Data Breach Practice AreasMay 12, 2021
- Robbins Geller Partners Aelish Baig and Jessica Shinnefield Recognized as “Born Leaders” and Plaintiffs’ Lawyers Trailblazers by The National Law JournalMay 4, 2021
- Robbins Geller Secures Appellate Win After Supreme Court of New York Appellate Division Affirms Denial of Motion to Dismiss in Securities Class Action Against Alnylam Pharmaceuticals, Inc.April 30, 2021
- April 29, 2021
- April 22, 2021